Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 3.90% vs 5.49% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 217.07% vs 130.11% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is 18.01% vs 11.29% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is -6.15% vs -13.39% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Amneal Pharmaceuticals, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -11.27% vs 3.80% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 3.90% vs 5.49% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 57.26% vs 174.03% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 217.07% vs 130.11% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 13.68% vs 29.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 18.01% vs 11.29% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is -4.98% vs -10.51% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -6.15% vs -13.39% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






